Home page | Association for Accessible Medicines
  • #Rx4Savings - Your Prescription for Savings
    Prescription for Savings
    Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.
  • Access! 2019 Brilliant Keynotes
    Brilliant Keynotes
    Some of the most influential speakers on the world stage share ours Feb 4-6 at Access! 2019. Hear directly from brilliant keynote speakers James Carville, Mary Matalin, Doug Long and more.
  • Generic Drugs are the Prescription for Savings
    More than 9 out of 10 generic drug prescriptions are filled for $20 or less.
  • Patients Can See Their Savings
    For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.
  • Preserve Patient Access in Trade Agreements
    The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Working to leave a positive impact on...

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Who We Are

Recent Updates

Video
Jan 17, 2019 | Christina Girardi
Rich's Story
Video
Jan 17, 2019 | Erica Klinger
Jonnie's Story
Video
Dec 14, 2018 | Erica Klinger
Keon's Story
Video
Dec 14, 2018 | Erica Klinger
Better Your Business at Access! 2019

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.